85
Views
3
CrossRef citations to date
0
Altmetric
Review

Current and emerging management options for patients with Morquio A syndrome

&
Pages 45-53 | Published online: 11 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christian J. Hendriksz. (2016) Elosulfase alfa (BMN 110) for the treatment of mucopolysaccharidosis IVA (Morquio A Syndrome). Expert Review of Clinical Pharmacology 9:12, pages 1521-1532.
Read now

Articles from other publishers (2)

Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Andrea Malfettone, José Manuel Pérez-García, Antonio Llombart-Cussac, Javier Cortés, Almudena Pardo & Jordi Pérez-López. (2020) The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II). International Journal of Environmental Research and Public Health 17:18, pages 6590.
Crossref
Sharon Barak, Yair Anikster, Ifat Sarouk, Eve Stern, Etzyona Eisenstein, Tamar Yissar, Nir Sherr-Lurie, Annick Raas-Rothschild & Dafna Guttman. (2020) Long-Term Outcomes of Early Enzyme Replacement Therapy for Mucopolysaccharidosis IV: Clinical Case Studies of Two Siblings. Diagnostics 10:2, pages 108.
Crossref